Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto (Idanha-a-Nova) Monsanto (Idanha-a-Nova) Monsanto is a village and a former civil parish in the municipality of Idanha-a-Nova, Portugal. In 2013, the parish merged into the new parish Monsanto e Idanha-a-Velha. It covered an area of 131.76 km² and had 828 inhabitants (June 30, 2011). It was the principal town of the "concelho" between 1174 and the beginning of the 19th century, and the county seat in the period of 1758-1853. In recent decades, Monsanto has become popularly known as "the most Portuguese village of Portugal" in a class of twelve classified historic villages in Portugal. The emblem of Portugal, the Silver